cell proliferation and antibody production (15, 18) . The interaction between Tse and Th is antigen-specific and major histocompatibility complex (Mhc)-restricted, and the suppression is manifested in the inhibition of the LDHB-specific, A-restricted proliferation of the Th cells. Because it is so well characterized, the anti-LDHn response provides an ideal system to study the mechanism of Tse-Th cell interaction.
We report here the functional characterization of monoclonal TseF secreted constitutively by T cell hybridomas. The latter were produced by fusing a long-term, LDHB-specific Tse cell line with the BW5147 thymoma. We use this factor to clarify the mechanism of Tse-Th cell interaction.
Materials and Methods
Mice. 8-15-wk-old male and female mice were obtained from our colony at the Max Planck Institute for Biology. The strains and their alleles at 1-1-2 loci are listed in Tables IV and VI. Antigens and Immunization. LDHB (LDH-H4 from pig heart; Boehringer, Mannheim, FR.G.), keyhole limpet hemocyanin (KLH; Calbiochem, Giessen, F.R.G.), poly(gluS°alaa°tyr 1°) (GAT; Miles-Yeda, Rehovoth, Israel) and UPC 10 (purified IgGz~ myeloma protein; Bionetics, Fresenius, Stuttgart, F.R.G.) were emulsified at 1/1 (vol/vol) ratio with complete Freund's adjuvant (CFA; Difco Hedinger, Stuttgart, F.R.G.), and 0.05 ml of the emulsion, containing 0.05 mg of antigen, was injected into mice subcutaneously, at the tail base. Concanavalin A (Con A) was purchased from Deutsche Wellcome (Burgwedel, F.R.G.).
Monoclonal Antibodies. Monoclonal A-and E-specific antibodies secreted by hybridomas B 15-124R1 (anti-Ia.m2), 13/4 (anti°Ia.m7; reference 19; the cell lines were obtained from Dr. G. J. H~immerling, German Cancer Research Center, Heidelberg, F.R.G.), 10.-2.16 (anti-Ia.ml7; reference 20; obtained from the Salk Institute, San Diego, CA), Y17 (anti-Ia.m44; reference 24; a gift from Dr. D. B. Murphy, Yale University School of Medicine Dept. of Pathology, New Haven, CT), and 25-9-17 (reacts with an unassigned A b determinant; reference 22; the hybridoma was obtained from Dr. D. H. Sachs, Transplantation Biology Section, Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD) were used in ascites form. Monoclonal antibodies 1L9, 2L2, and 14P, specific for a molecule controlled by a locus in the A~-Ep interval and selectively expressed by T cells, were produced as described previously (23) .
Production of Hybridomas Secreting LDHB-Specific TseF. Long-term Tse cell line was established from LDHB-immune lymph node-cells of B 10.A(2R) (suppressed nonresponder) mice. The Lyt-1 +2 + set containing LDHB-specifie Tse was separated by positive selection of Lyt-1 +2 + and Lyt-1-2 + cells with a monoclonal Lyt-2.2 specific antibody followed by the selection of Lyt-l+2 + cells with a monoelonal Lyt-1.2 specific antibody (17) , and the cells (1 × 10$/ml) were cultured in Alpha minimal essential medium (Gibco, BCK Biocuh-Chemie, Karlsruhe, F.R.G.) supplemented with 10% FCS, antibiotics, L-glutamine, and 2-mercaptoethanol, in the presence of 15 #g/ml LDHB and syngeneic, irradiated (3,300 R) spleen cells (2.5 × 10e/ml) as feeder cells, for 1 wk, followed by another week of culture in the presence of antigen, feeder cells, and T cell growth factor (TCGF; 48 h supemate of Con A-stimulated mouse spleen cells). After three such culture cycles, the cells were expanded by weekly restimulations with LDHB, TCGF, and feeder cells. The cultured cells were found to suppress the LDHa-specific proliferation of Lyt-l+2cells in an antigen-specific and Mhc-restricted fashion. Cells of the 4-mo-old Tse line were fused with the BW5147 thymoma, and the hybridomas were selected using standard methods (4, 24) . The hybridoma supernates were screened for suppression of the antlgen-specific proliferation of LDHB-primed syngeneie Lyt-I+2 -cells. Six hybridomas (2RL-Ts-1 through 6) were found to secrete, in the absence of antigen, a suppressive material. Two of these hybridomas (2RL-Ts-1 and 5) were recloned (at a density of 0.3 cell/well). All clones tested were positive, and secreted TsF that was functionally indistinguishable from that produced by uncloned lines. Therefore, in the experiments described here, supernates of cloned and uncloned hybridomas were used indiscriminately.
Testing the Effect of TseF on Antigen-specific T Cell Proliferation. Immune lymph-node cells or the Lyt-l+2 -fraction thereof (obtained by separation on anti-mouse IgG-coated dishes after treatment with Lyt-2.2-specific antibody, as described in reference 17) were tested for antigenspecific response in a standard 3-d proliferation assay (25) . Different dilutions of the TseF or of a control factor (supernate of the BW5147 line) were included in the same culture volume (0.2 ml) and were present throughout the culture. Alternatively, the immune Lyt-l+2 -cells were preincubated with factors at predetermined dilutions at 37°C for 6 h, the cells were then washed and tested for proliferation in the 3-d assay. The cultures were set up in triplicate, and the results were expressed as A cpm (the difference ofcpm in cultures with and without antigen) and as stimulation index (S.I.; the ratio of cpm in cultures with and without antigen).
Absorption of TseF. 1-mt aliquots of hybridoma supernatant diluted to 1:4 or 1:10 with culture medium, were incubated for 1 h on ice with 2-4 X 10 v cells using different cell populations as shown in Table IV . The cells were then centrifuged and the supernates were removed and tested for TseF activity by including them, at a final dilution of 1:20 or 1:40, into the 3-d proliferation cultures containing LDHB-primed Lyt-1+2 -cells.
T~psin Treatment of Cells. The Lyt-l+2 -fraction of LDHB-primed lymph-node cells was treated with trypsin (2.5 mg/ml) in the presence of DNAse I (20/~g/ml) according to the method described previously (26) . The recovered cells were washed three times, cultured overnight in a medium containing 25% TCGF, and tested for functional activity in the 3-d proliferation assay, with or without previous exposure (6 h) to TseF.
Generation of Allorestricted T Cells. T cells recognizing antigen in the context of allogeneic A
molecules were generated by in vitro priming to LDHB on allogeneie APC, after the removal of alloreactive cells with 5-bromo-2'-deoxyuridine and light treatment. Here we used a recently described 2 modification of the original method (27) .
Results
The Effect of Hybridoma-produced TseF on Th Cells is Antigen-specific and Mhc-Restricted. Hybridoma supernates, when included in the 3-d proliferation assay, inhibited to background levels the response of LDHB-primed Lyt-l+2 -cells from B 10.AL and B 10.A(2R) mice (unseparated cells from these strains are nonresponders to LDHB because of the presence of Lyt-1+2 + Tse cells; references 15-17), but did not influence the proliferative response of KLH-primed and GAT-primed B 10.A(2R) cells (Table I) . Thus the suppressive effect of these factors is antigen-specific. However, the LDHs-specific TseF completely suppressed the proliferative response of T ceils to the 2 Baxevanis, G. N., Z. A. Nagy, and J. Klein. 1983 . The nature of the interaction between suppressor and helper T cells in the response to LDHB. Manuscript submitted for publication. ND, not done. * Cells were incubated at 37°C with hybridoma supernate at a 1:2 dilution, washed, and tested for proliferation. * The concentration of Con A was 25/zg/ml; LDHs and GAT were used at concentrations given in Table  I. IgG2. myeloma protein UPC 10 (Table II) . This finding confirms our previous observation that the Tse cells involved in the anti-LDHB and anti-IgG2, responses cross-react completely (28) . The crude hybridoma supernates caused complete suppression of T cell proliferation at a dilution up to more than 1:500 (data not shown).
Cross-Suppression of lgG~-Specific T-cell Proliferation by the LDHB-Specific TseF
The data in Table III demonstrate that a short term (4 h) exposure of cells to the factor is sufficient to cause complete suppression, indicating that the factor is a TseF that acts directly on the Th cells. The interaction of TseF with Th is Mhc-restricted (Table IV) . The strains used as Th donors map this restriction to the A,-E~ interval, and excludes the involvement of all other H-2 regions (also theJ region), and of non-H-2 genes. Since the action of the LDHB-specific Tse cells on Th cells is also shortterm, antigen-specific, and A-restricted, the hybridoma TseF can be considered as the secreted form of the molecule responsible for the Tse-Th cell interaction. ND, Not done. (Table V) . In contrast, syngeneic Lyt-2-bearing cells primed to LDHB, or syngeneic Lyt-l+2 -cells primed to CAT do not absorb the factor. Similarly, LDHn-pulsed or unpulsed spleen cells from unprimed syngeneic mice are unable to absorb the factor. Thus the TseF binds to the cells on which it acts (LDHB-specific Th cells), but fails to bind to LDHB-primed non-Th cells, to Th cells of irrelevant specificity, or to APC. The binding of TseF to Th cells is subject to the same genetic restriction as its functional activity, that is, the factor is only absorbed by LDHB-primed Th cells that share genes in the A,~-Ea interval with the factor-producing cells (Table VI) . Thus the factor acts after binding to its target cell in an antigen-specific and Mhc-restricted fashion.
Mhc-Restricted Absorption of TseF Activity with LDHn-Specific Th Cells. The suppres-
Antigen Requirement of TseF-Th Cell Interaction. The antigen specificity of TseFbinding to Th cells can reflect either a direct receptor-receptor interaction (for example, idiotype-antiidiotype reaction) or an indirect interaction through an antigen bridge. To distinguish between these possibilities, we tested whether antigen is necessary for the TseF to act on Th cells. To conclusively demonstrate this point, one first has to ensure that the experimental system is devoid completely of antigen. This requirement is met in the case of the TseF used, since the factor is secreted by hybridomas in the absence of LDHB. However, the Th cells might have carried LDHB, and so, to preclude this possibility we trypsinized them to remove the surfacebound antigen. Because trypsin also attacks cell-membrane proteins (29) , the cells were allowed to resynthesize their receptors during an overnight incubation in antigenfree medium. The interaction of these cells with TseF was then tested in a short term (6 h) culture, with or without LDHB. The cells were then washed, and tested for antigen-specific proliferation. Suppression ensued during the 6-h exposure of Th cells to TseF only when antigen was added to the system (Table VII) . Furthermore, trypsin-treated Th cells regenerated their capacity to proliferate to LDHB but they were unable to absorb TseF in the absence of antigen (Z. Ikezawa, unpublished results). We conclude, therefore, that an antigen-bridge is necessary for the TseF to bind to and act on Th cells.
The Mechanism of Mhc-Restriction in the Interaction between TseF and Th Cells. The data
in Tables IV and VI have demonstrated that the TseF only suppresses Th cells that share the A~E O interval genes with the factor-producing cells. We have previously shown that the same genetic restriction applies to the Tse-Th cell interaction in the anti-LDHB response (17) . Further analysis has revealed that the Tse-Th cell interaction is determined by the receptor of Th cells (anti-LDHB + A k) and the presence of Ak-alleles in the genome of Tse cells. 2 We inferred from these data that the interaction is based on the recognition by Th cells of Ak-controlled determinants expressed on the Tse cells. If this hypothesis is valid, the TseF that exhibits identical genetic restriction to that of the Tse cell, must carry Ak-controlled antigenic determinants. We therefore tested whether Ak-specific monoclonal antibodies can abrogate the effect of TseF on Th cells. The factor was preincubated with the antibodies and then allowed to interact with LDHB-primed Lyt-1+2 -cells for 6 h. The cells were then washed and tested for LDHe-specific proliferation in a 3-d assay. As shown in Table VIII , antibodies against the known class II Mhc molecules (A and E) did not interfere with the activity of TseF. Interestingly, however, monoclonal antibodies IL9 and 14P that recognize A~-Ea interval-controlled T-cell specific determinants (23) completely neutralized the TseF. Another antibody of the T-cell-specific "anti-A k'' series, 2L2, had the same effect, whereas antibody 1G8 that reacts with Tsi cells (T. Tada et al., unpublished data) had no effect on the TseF (Z. Ikezawa, unpublished results). Antibodies 1L9, 2L2, and 14P, when included in the assay cultures, neutralized the added TseF, but did not block the A~A~-restricted proliferation of Th cells (Table IX) . Furthermore, the antibodies did not affect the capacity of Th cells to absorb the TseF (Z. Ikezawa, unpublished data). Thus, the antibodies recognize Ak-like determinants carried by the factor, but absent from the APC and Th cells. We have investigated also whether 
Inhibition of TseF Activity by T Cell-specific Anti-A k Antibodies

Discussion
In this communication we have functionally characterized a monoclonal TseF secreted constitutively by hybridomas that were made by fusing a long-term, LDHBspecific Tse cell line with the BW5147 thymoma. In terms of specificity and function, the TseF is equivalent to the Tse cell itself (17) , and can thus be considered the effector molecule of the latter. The factor consists of two functional parts, one that binds LDHB, and another that carries or mimics the A k determinant(s) recognized by the Th cells on the APC. For the suppression to occur, a double bond between TseF and Th cell has to be established, that is, the TseF must bind to the anti-LDHB receptor of Th cells through an antigen bridge, and the Ak-like determinants of the factor must be bound by the anti-A k receptor of the Th cell. (Whether the anti-LDHB and anti-A k binding sites of Th cells are physically linked remains unknown.) When one of these binding events is prevented from occurring by either the removal of LDHB from the system, or blocking of the Ak-like moiety with antibodies, no suppression occurs. The crucial role of Ak-like determinants in suppression has also been demonstrated by an independent line of evidence, namely by the observation that LDHa-primed T cells from suppressed nonresponder strains can be turned responder by including in the cultures any of the T-cell-specific monoclonal "anti-A k'' antibodies (23) used in this study (Z. Ikezawa et al., manuscript in preparation). The requirement for a dual recognition explains the antigen-specificity and the A krestriction of the interaction between the TseF (or the Tse cells) and the Th cells 2 (17) . Once the TseF is bound to the Th cells, the suppression ensues within a matter of hours.
Many of the suppressor factors characterized so far resemble the TseF described here, in that they possess a binding site specific for either the immunizing antigen (4-7, 9-13, 30, 31) or a receptor-idiotype of the target cell (8) , and carry Mhc-controlled antigenic determinants (4-10, 12, 30, 31) . The anti-antigen-or antiidiotype-binding site determines the factor-target cell interaction in all known suppressor systems. The Mhc determinants, in many but not all systems, impose a genetic restriction on the factor-target cell interaction (4, 6-8, 12, 32) . Thus, the interaction of these and some additional factors (33, 34) with their targets appears to involve dual recognition, similar to the LDHs-specific TseF. One important difference between the LDHBspecific TseF and all other known factors is that the former carries an A,~E~ intervalcontrolled moiety instead of determinants controlled by the so-called J region. This fortunate situation permitted us to analyze the A-like moiety by comparison with its well-characterized, counterl~art , the A~A~ cla~s II molecule. The data have demonstrated that there are determinants shared between APC-derived and TseF-derived A molecules, namely those that serve as restriction elements for antigen-recognition by Th cells. The factor-derived A-moiety carries additional determinants that are absent from APC (or B ceU)-derived A molecules (those recognized by the T cell-specific monoclonal "anti-A k'' antibodies), and lacks serologically detectable determinants of the classical A molecule. Whether the two types of A molecule are controlled by different genes remains to be seen. Considering the relative paucity of class II genes in the A,~E~ interval (35) , it is more likely that they represent different variants of a single gene product. By analogy, it is tempting to speculate that the so-called .J molecule may be an analogous modification of another known class II gene product, perhaps the E~ chain.
Summary
Hybridomas secreting a monoclonal T suppressor-effector factor (TseF) were produeed by fusion of a lactate dehydrogenase B (LDHB)-specific long-term T suppressoreffector (Tse) cell line with the BW5147 thymoma. A short exposure (4 h) to TseF completely suppresses the antigen-specific and A-restricted proliferation of LDHBprimed Lyt-l+2 -[possibly helper (Th)] cells. The action of TseF on Th cells, as that of the Tse cells themselves, is antigen-specific and A-restricted. The interaction of TseF with Th cells involves two binding events, of which one occurs via antigen bridge, and the other represents the recognition of a factor-derived Ak-like moiety by the anti-A k receptor of Th cells. The Ak-like moiety of the TseF carries the determinants that serve as restriction elements for antigen recognition by Th cells, and additional determinants demonstrable by T cell-specific monoclonal "anti-A k'' antibodies, however, it lacks serologically detectable determinants of the B cell-derived A~At~ class II Mhc molecules.
